Lymphoma Clinical Trials

Completed

Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma

NCT00606645

Conditions: Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: Rush University Medical Center Chicago, Illinois, United States

Ohio State University Columbus, Ohio, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00109967

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Mobile Infirmary Medical Center Mobile, Alabama, United States

The Medical Center of Aurora Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose-Saint Francis Healthcare Colorado Springs, Colorado, United States

View all 195 locations

View Trial Details

Completed

CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma

NCT00033267

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: North Central Cancer Treatment Group Rochester, Minnesota, United States

View Trial Details

Completed

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

NCT01233921

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Safety of PCI-32765 in Chronic Lymphocytic Leukemia

NCT01105247

Conditions: B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +18 more
Locations: Stanford University School of Medicine Stanford, California, United States

New York Presbyterian Hosptial Cornell Med Center New York, United States

The Ohio State University Columbus, Ohio, United States

Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States

View Trial Details

Completed

A Study of SGN-40 in Combination With Rituximab in Patients With CD20-Positive, Follicular and Marginal Zone B-Cell Non-Hodgkin's Lymphoma

NCT00556699

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Not specified

View Trial Details

Completed

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

NCT00890747

Conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
Locations: Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States

Northwestern University Chicago, Illinois, United States

AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States

View Trial Details

Completed

Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

NCT00322491

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

UCLA School of Medicine Loa Angeles, California, United States

Loyola University Medical Center Maywood, Illinois, United States

University of Iowa Iowa City, Iowa, United States

View Trial Details

Completed

AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease

NCT00396201

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +7 more
Locations: Washington University School of Medicine,Division of Bone Marrow Transplantation & Leukemia St Louis, Missouri, United States

View Trial Details

Completed

Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients

NCT00322387

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: City of Hope National Medical Center Duarte, California, United States

Indiana Blood and Marrow Transplantation Beech Grove, Indiana, United States

University of Rochester Medical Center Rochester, New York, United States

Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions